No Data
Stocks that moved the day before part2 Abalance, Sockets, etc.
Stock name <Code> Closing price on the 27th ⇒ Change from previous day mazda motor crp <7261> 944.8 -55.1 Seeing the yen's strength in the foreign exchange market as a selling point. nissan motor co <7201> 373.5 -18.6 Continues to view negative factors such as prolonged production cuts in the United States. tokyu <9005> 1752 -80 Viewing the sale settlement cross in off-hours trading as a factor. hino motors <7205> 392.8 -15.9 Pressured by the downward trend in automobile stocks. mitsubishi motors <7211> 403.9 -20.2 Strengthening of the yen.
Emerging Markets Stock Digest: Daiomu significantly declines, Chordia rebounds significantly after 3 days.
<2160> GNI 2953 +145 sharply extended. They are disclosing questions and answers from investors. On the 14th, the consolidated subsidiary Cullgen entered into a contract for a reverse merger with Pulmatrix, listed on the Nasdaq, and expected to record other income of approximately 14.7 billion 64 million yen (with a stock valuation gain of approximately 10.7 billion 68 million yen), but following an increase in Pulmatrix's stock price, in this disclosure, it was mentioned that "the stock valuation gain we record is also significantly increased".
Active and newly listed stocks during the morning session.
*Dai-Doo Group HD <2590> 3240 +326 The cumulative operating profit for the third quarter has turned into an increase. *Janome <6445> 1187 +82 The upward trend in stock prices continues, and buybacks are becoming more active. *Keisei Electric Railway <9009> 4662 +243 Viewed as a material for the sale of shares in OLC shareholding. *Resonac <4004> 4170 +178 Interest as a related company to perovskite solar cells. *Oriental Land Co., Ltd. Unsponsored ADR <4661> 3585 +150 Responding to the sale of shares in Keisei Electric Railway.
Kaiom - significantly declined, with a candidate antibody for cancer treatment undergoing patent examination in china, leading to profit-taking sell.
Marked decline. It has been announced that the patent application for the candidate antibody for cancer treatment, the humanized DLK-1 antibody, has received a patent assessment notification in China. It pertains to the combination of a humanized monoclonal antibody targeting human DLK-1 and lenvatinib, used as a therapeutic agent for liver cancer, with patents granted in Japan and applications pending in the US and Europe. However, shares of Kaiom Bioscience Co., Ltd. have surged in a short period, including reaching a new year-to-date high the previous day, prompting profit-taking sales.
Supported by a firm and resilient US stock market, among other factors.
[Emerging Market Individual Stock Strategy] Today's emerging markets are expected to show a strong performance. In the U.S. stock market on the 26th, the Dow Jones Industrial Average rose by 123.74 points to 44,860.31, a 5-day winning streak with a increase of +0.28%. While concerns were raised about the tariff proposal made by the future President Trump and the lackluster earnings of some companies, there was a sense of reassurance due to the rebound of the semiconductor Nvidia (NVDA). Additionally, there were reports that the Israeli security cabinet approved a ceasefire agreement with Lebanon and the Federal Open Market Committee in November.
Stocks that moved the previous day part 2: Disco, Kuroganekousakusho, Bouldera etc.
Oka San Securities downgraded its investment rating.
No Data
No Data